AGP Executive Report
Last update: 7 hours agoWHO–Gilead VL Push: Gilead renewed a five-year partnership with the World Health Organization to eliminate visceral leishmaniasis (kala-azar), pledging 402,941 vials of AmBisome plus $9.2m for diagnosis and treatment—sharply focused on high-burden East Africa, including Ethiopia. Health Workforce Mobility: Ethiopia and Barbados signed an MoU to support ethical recruitment and workforce mobility of Ethiopian health professionals, aiming to ease shortages while keeping standards transparent. Digital ID for Services: Ethiopia’s Fayda expansion is calling for “Super Agents” to speed up large-scale registration and reach underserved groups, after major enrollment and authentication gains. Humanitarian Funding Warning: Germany’s DAAD warns that planned budget cuts could suspend most international academic cooperation by 2031, raising concerns for capacity-building links that support health and research. Climate Risk for Health: IGAD’s seasonal outlook flags below-normal rainfall across parts of the northern Greater Horn—an early warning for food and water stress that can quickly become a health issue.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/179f22ed1a6a3c1d57925a4827178fc8a26ce057-1280x720.png)
